CDIB Capital International
Hong Kongcdibcapitalgroup.com
Overview
CDIB Capital International is the private equity and overseas investment arm of CDIB Capital Group, specializing in middle-market buyouts, recapitalization, corporate divestiture, growth equity, and mid-to-late-stage venture capital transactions.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Rivos | Apr 2024 | Series A Extension | Co-investor |
| Anbogen Therapeutics | Jan 2024 | Series A | Lead |
| QT Medical, Inc. | Sep 2023 | Series B | Lead |
| TXOne Networks | Aug 2022 | Series B | Co-investor |
| AIdoc | Jun 2022 | Series D | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.